top of page
News
Chat
Insights
Portfolios
Education
About
Pricing
BPIQ API
BPIQ APEX
Acumen Pharmaceuticals: A Risky Bet Through Upcoming Data Readout
Intro:
Jul 12, 2023
New Era In Alzheimer's Treatments Brings Opportunities for Biopharma Investors
ALHEIMER’S BREAKTHROUGH
Jun 19, 2023
HAS THE MARKET BEEN TOO HARSH ON $ABOS?
HAS THE MARKET BEEN TOO HARSH ON $ABOS?
Apr 8, 2023
How does Lecanemab compare to other Alzheimer's assets?
Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
Jan 4, 2023
How does Lecanemab compare to other Alzheimer's assets?
Summary:
Jan 4, 2023
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
